Ionis Pharma (IONS) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Ionis Pharmaceuticals (IONS) PT Raised to $57 at Stifel
February 28, 2018 6:39 AM ESTStifel raised its price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $57.00 (from $55.00) while maintaining a Hold rating.
Analyst Stephen Willey notes SPINRAZA royalties highlight increasing leverage, with IONIS-HTTRx data now on deck.
... More